Dr. Rik Peeperkorn, World Health Organization (WHO) Representative in the occupied Palestinian territoryو has warned that the ongoing ban on humanitarian aid into Gaza is severely limiting the ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

A new study from Lund University in Malmö, Sweden, revealed that waist circumference is a stronger risk indicator for obesity ...

Scott MacMillan was relieved when doctors were able to save the life of his daughter, Rosemary, who was in diabetic ...

President of the United States Donald Trump has reportedly lost 30lbs since 2022, with images showing him to have a slimmer ...

Donald Trump has lost a significant amount of weight in the past year, and while fans have praised his new look, one expert ...

In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

CGM approved by FDA for adults with diabetes; U.S. launch set for late 2025 with extended wear and advanced tracking features ...

This popular spice is beloved by many, but its potential interactions with certain medications are important to be aware of.

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

The doctors say barriers continue to prevent access to AID, including costs. Such barriers exemplify “the implicit ...